Sergio Barrondo Lacarra-rekin lankidetzan egindako argitalpenak (24)

2024

  1. PLCβ1 by-passes early growth response -1 to induce the differentiation of neuronal cells

    Cell Death Discovery, Vol. 10, Núm. 1

2023

  1. Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods

    Microbial Cell Factories, Vol. 21, Núm. 1

  2. Isolation of Platelet-Derived Exosomes from Human Platelet-Rich Plasma: Biochemical and Morphological Characterization

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  3. Up-regulation of CB1 cannabinoid receptors located at glutamatergic terminals in the medial prefrontal cortex of the obese Zucker rat

    Frontiers in Neuroanatomy, Vol. 16

2021

  1. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Histochemistry and Cell Biology, Vol. 156, Núm. 5, pp. 479-502

  2. Lack of the Transient Receptor Potential Vanilloid 1 Shifts Cannabinoid-Dependent Excitatory Synaptic Plasticity in the Dentate Gyrus of the Mouse Brain Hippocampus

    Frontiers in Neuroanatomy, Vol. 15

  3. Subsynaptic distribution, lipid raft targeting and g protein-dependent signalling of the type 1 cannabinoid receptor in synaptosomes from the mouse hippocampus and frontal cortex

    Molecules, Vol. 26, Núm. 22

2020

  1. Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice

    Neuropsychopharmacology, Vol. 45, Núm. 2, pp. 309-318

  2. Teratokartzinometatik eratorritako zelula-lerro neuronalen (NT2N) trasplantea: istripu zerebrobaskularra izandako gaixo kronikoentzako estrategia terapeutiko berria.

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 38, pp. 27-40

2019

  1. Ketaminaren eragin antidepresiboak. Ekintzamekanismo berriak farmako antidepresiboen bilaketarako

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 35, pp. 41-56

2016

  1. Data for the morphometric characterization of NT2-derived postmitotic neurons

    Data in Brief

  2. Highly efficient generation of glutamatergic/cholinergic NT2-derived postmitotic human neurons by short-term treatment with the nucleoside analogue cytosine β-d-arabinofuranoside

    Stem Cell Research, Vol. 16, Núm. 2, pp. 541-551

2015

  1. New Insights into Gene Delivery to Human Neuronal Precursor NT2 Cells: A Comparative Study between Lipoplexes, Nioplexes, and Polyplexes

    Molecular Pharmaceutics, Vol. 12, Núm. 11, pp. 4056-4066

  2. Nuclear diacylglycerol lipase-α in rat brain cortical neurons: Evidence of 2-arachidonoylglycerol production in concert with phospholipase C-β activity

    Journal of Neurochemistry, Vol. 132, Núm. 5, pp. 489-503

2014

  1. Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons

    Advances in Biological Regulation, Vol. 54, Núm. 1, pp. 12-23

2013

  1. Sistema endokannabinoidea: etorkizun handiko itu terapeutikoa gaixotasun psikiatrikoetan

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 1, pp. 115-127

2012

  1. Cellular neurochemical characterization and subcellular localization of phospholipase C β1 in rat brain

    Neuroscience, Vol. 222, pp. 239-268

  2. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5

    FASEB Journal, Vol. 26, Núm. 12, pp. 4841-4854

2010

  1. Gi protein coupling to adenosine A1-A2A receptor heteromers in human brain caudate nucleus

    Journal of Neurochemistry, Vol. 114, Núm. 4, pp. 972-980